» Articles » PMID: 32554938

Visualization of Procollagen IV Reveals ER-to-Golgi Transport by ERGIC-independent Carriers

Overview
Specialty Cell Biology
Date 2020 Jun 20
PMID 32554938
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Collagen is the most abundant protein in animal tissues and is critical for their proper organization. Nascent procollagens in the endoplasmic reticulum (ER) are considered too large to be loaded into coat protein complex II (COPII) vesicles, which have a diameter of 60-80 nm, for exit from the ER and transport to the Golgi complex. To study the transport mechanism of procollagen IV, which generates basement membranes, we introduced a cysteine-free GFP tag at the N-terminus of the triple helical region of the α1(IV) chain (cfSGFP2-col4a1), and examined the dynamics of this protein in HT-1080 cells, which produce endogenous collagen IV. cfSGFP2-col4a1 was transported from the ER to the Golgi by vesicles, which were a similar size as small cargo carriers. However, mCherry-ERGIC53 was recruited to α-antitrypsin-containing vesicles, but not to cfSGFP2-col4a1-containing vesicles. Knockdown analysis revealed that Sar1 and SLY1/SCFD1 were required for transport of cfSGFP2-col4a1. TANGO1, CUL3, and KLHL12 were not necessary for the ER-to-Golgi trafficking of procollagen IV. Our data suggest that procollagen IV is exported from the ER via an enlarged COPII coat carrier and is transported to the Golgi by unique transport vesicles without recruitment of ER-Golgi intermediate compartment membranes.Key words: collagen, procollagen IV, endoplasmic reticulum, ER-to-Golgi transport, ERGIC.

Citing Articles

effector EgeA facilitates infection by hijacking TANGO1 and SCFD1 from ER-Golgi exit sites to pathogen-occupied inclusions.

Wang L, Lin M, Hou L, Rikihisa Y Proc Natl Acad Sci U S A. 2024; 121(33):e2405209121.

PMID: 39106308 PMC: 11331065. DOI: 10.1073/pnas.2405209121.


Insights into How Plant-Derived Extracts and Compounds Can Help in the Prevention and Treatment of Keloid Disease: Established and Emerging Therapeutic Targets.

Boo Y Int J Mol Sci. 2024; 25(2).

PMID: 38279232 PMC: 10816582. DOI: 10.3390/ijms25021235.


PLEKHA4 is a novel prognostic biomarker that reshapes the tumor microenvironment in lower-grade glioma.

Zhi W, Wang Y, Jiang C, Gong Y, Chen Q, Mao X Front Immunol. 2023; 14:1128244.

PMID: 37818357 PMC: 10560889. DOI: 10.3389/fimmu.2023.1128244.


Ascorbic Acid (Vitamin C) as a Cosmeceutical to Increase Dermal Collagen for Skin Antiaging Purposes: Emerging Combination Therapies.

Boo Y Antioxidants (Basel). 2022; 11(9).

PMID: 36139737 PMC: 9495646. DOI: 10.3390/antiox11091663.


Endoplasmic reticulum-to-Golgi trafficking of procollagen III via conventional vesicular and tubular carriers.

Hirata Y, Matsui Y, Wada I, Hosokawa N Mol Biol Cell. 2022; 33(3):ar21.

PMID: 35044867 PMC: 9250382. DOI: 10.1091/mbc.E21-07-0372.


References
1.
Zhu M, Tao J, Vasievich M, Wei W, Zhu G, Khoriaty R . Neural tube opening and abnormal extraembryonic membrane development in SEC23A deficient mice. Sci Rep. 2015; 5:15471. PMC: 4616029. DOI: 10.1038/srep15471. View

2.
Ishikawa Y, Ito S, Nagata K, Sakai L, Bachinger H . Intracellular mechanisms of molecular recognition and sorting for transport of large extracellular matrix molecules. Proc Natl Acad Sci U S A. 2016; 113(41):E6036-E6044. PMC: 5068301. DOI: 10.1073/pnas.1609571113. View

3.
Bella J, Liu J, Kramer R, Brodsky B, Berman H . Conformational effects of Gly-X-Gly interruptions in the collagen triple helix. J Mol Biol. 2006; 362(2):298-311. DOI: 10.1016/j.jmb.2006.07.014. View

4.
Liu M, Feng Z, Ke H, Liu Y, Sun T, Dai J . Tango1 spatially organizes ER exit sites to control ER export. J Cell Biol. 2017; 216(4):1035-1049. PMC: 5379956. DOI: 10.1083/jcb.201611088. View

5.
Yu S, Satoh A, Pypaert M, Mullen K, Hay J, Ferro-Novick S . mBet3p is required for homotypic COPII vesicle tethering in mammalian cells. J Cell Biol. 2006; 174(3):359-68. PMC: 2064232. DOI: 10.1083/jcb.200603044. View